Greylin Investment Mangement Inc Amgen Inc Transaction History

Greylin Investment Mangement Inc

$566 Million
Q2 2024

A detailed history of Greylin Investment Mangement Inc transactions in Amgen Inc stock. As of the latest transaction made, Greylin Investment Mangement Inc holds 14,971 shares of AMGN stock, worth $3.96 Million. This represents 0.83% of its overall portfolio holdings.

Number of Shares

14,971

Previous 15,860 5.61%

Holding current value

$3.96 Million

Previous $4.51 Million 3.73%

% of portfolio

0.83%

Previous 0.76%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	SELL	$262.75 - $319.31 $233,584 - $283,866	-889 Reduced 5.61%	14,971 $4.68 Million
Q1 2024 Apr 24, 2024	SELL	$268.87 - $324.56 $3.95 Million - $4.77 Million	-14,707 Reduced 48.11%	15,860 $4.51 Million
Q4 2023 Jan 25, 2024	SELL	$255.7 - $288.46 $1.03 Million - $1.16 Million	-4,034 Reduced 11.66%	30,567 $8.8 Million
Q3 2023 Oct 10, 2023	SELL	$218.65 - $271.46 $808,349 - $1 Million	-3,697 Reduced 9.65%	34,601 $9.3 Million
Q2 2023 Jul 10, 2023	BUY	$214.27 - $253.37 $61,281 - $72,463	286 Added 0.75%	38,298 $8.5 Million
Q1 2023 Apr 07, 2023	SELL	$225.79 - $275.2 $92,799 - $113,107	-411 Reduced 1.07%	38,012 $9.19 Million
Q4 2022 Jan 25, 2023	SELL	$229.03 - $291.01 $65,273 - $82,937	-285 Reduced 0.74%	38,423 $0
Q3 2022 Oct 13, 2022	SELL	$224.46 - $253.15 $311,326 - $351,119	-1,387 Reduced 3.46%	38,708 $8.73 Million
Q2 2022 Jul 11, 2022	SELL	$230.71 - $256.74 $99,666 - $110,911	-432 Reduced 1.07%	40,095 $9.76 Million
Q1 2022 May 20, 2022	BUY	$219.27 - $242.57 $119,282 - $131,958	544 Added 1.36%	40,527 $9.8 Million
Q4 2021 Feb 15, 2022	BUY	$198.88 - $227.6 $3.56 Million - $4.07 Million	17,892 Added 80.99%	39,983 $9 Million
Q3 2021 Oct 13, 2021	BUY	$212.27 - $248.7 $4.26 Million - $4.99 Million	20,046 Added 980.24%	22,091 $4.7 Million
Q2 2021 Jul 14, 2021	BUY	$233.58 - $259.14 $32,934 - $36,538	141 Added 7.41%	2,045 $498,000
Q1 2021 May 12, 2021	BUY	$221.91 - $258.6 $29,292 - $34,135	132 Added 7.45%	1,904 $474,000
Q4 2020 Jan 14, 2021	BUY	$216.38 - $257.67 $2,163 - $2,576	10 Added 0.57%	1,772 $407,000
Q3 2020 Oct 13, 2020	SELL	$234.65 - $260.95 $888,150 - $987,695	-3,785 Reduced 68.24%	1,762 $448,000
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $343,200 - $421,153	-1,735 Reduced 23.83%	5,547 $1.31 Million
Q1 2020 Apr 09, 2020	SELL	$182.24 - $241.7 $957,671 - $1.27 Million	-5,255 Reduced 41.92%	7,282 $1.48 Million
Q4 2019 Jan 09, 2020	SELL	$189.21 - $243.2 $628,177 - $807,424	-3,320 Reduced 20.94%	12,537 $3.02 Million
Q3 2019 Oct 11, 2019	SELL	$174.11 - $208.62 $9,576 - $11,474	-55 Reduced 0.35%	15,857 $3.07 Million
Q2 2019 Aug 15, 2019	BUY	$166.7 - $195.41 $530,106 - $621,403	3,180 Added 24.98%	15,912 $2.93 Million
Q1 2019 Apr 09, 2019	SELL	$180.87 - $203.88 $45,217 - $50,970	-250 Reduced 1.93%	12,732 $2.42 Million
Q4 2018 Jan 14, 2019	SELL	$178.4 - $208.25 $495,060 - $577,893	-2,775 Reduced 17.61%	12,982 $2.53 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $4,632 - $5,222	25 Added 0.16%	15,757 $3.27 Million
Q2 2018 Aug 07, 2018	BUY	$166.05 - $186.51 $214,536 - $240,970	1,292 Added 8.95%	15,732 $2.9 Million
Q1 2018 May 14, 2018	BUY	$169.43 - $198.0 $9,318 - $10,890	55 Added 0.38%	14,440 $2.46 Million
Q4 2017 Jan 16, 2018	BUY	$168.79 - $188.59 $55,363 - $61,857	328 Added 2.33%	14,385 $2.5 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $2.35 Million - $2.68 Million	14,057	14,057 $2.62 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Greylin Investment Mangement Inc, based on Form 13F filings with the SEC.

News

Stay updated on Greylin Investment Mangement Inc with notifications on news.

Account

Greylin Investment Mangement Inc Amgen Inc Transaction History